CoChat

Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

BACKGROUND Salmonella enterica is a major global food-borne pathogen, causing life-threatening infections. Ciprofloxacin and extended-spectrum cephalosporins (ESCs) are the drugs of choice for severe infections. We previously reported a ciprofloxacin-resistant S. enterica serotype Kentucky (S Kentucky) ST198-X1 strain that emerged in Egypt and spread throughout Africa and the Middle East from 2002 to 2008. We aimed to monitor recent trends in the location of transmission and antimicrobial resistance of this strain. METHODS We analysed isolates of S Kentucky collected by the French national surveillance system for salmonellosis in France from Jan 1, 2000, to Dec 31, 2011, and at two sites in Casablanca, Morocco, between Jan 1, 2003, and Dec 31, 2011. We analysed patterns of travel of patients infected with a ciprofloxacin-resistant strain of S Kentucky. We identified isolates showing resistance to ESCs or decreased susceptibility to carbapenems, characterised isolates by XbaI-pulsed field gel electrophoresis and multilocus sequence typing, and assessed mechanisms of bacterial resistance to antimicrobial drugs. FINDINGS 954 (1%) of 128,836 serotyped Salmonella spp isolates in France were identified as S Kentucky, as were 30 (13%) of 226 Salmonella spp isolates from Morocco. During 2000-08, 200 (40%) of 497 subculturable isolates of S Kentucky obtained in France were resistant to ciprofloxacin, compared with 376 (83%) of 455 isolates in 2009-11, suggesting a recent increase in ciprofloxacin resistance in France. Travel histories suggested S Kentucky infections originated predominantly in east Africa, north Africa, west Africa, and the Middle East, but also arose in India. We report several occurrences of acquisition of extended-spectrum β-lactamase (CTX-M-1, CTX-M-15), plasmid-encoded cephalosporinase (CMY-2), or carbapenemase (OXA-48, VIM-2) genes by ciprofloxacin-resistant isolates of S Kentucky ST198-X1 from the Mediterranean area since 2009. Many of these highly drug-resistant isolates were also resistant to most aminoglycosides, to co-trimoxazole (trimethoprim-sulfamethoxazole), and to azithromycin. INTERPRETATION The potential risk to public health posed by ciprofloxacin-resistant S Kentucky ST198-X1 warrants its inclusion in national programmes for the control of S. enterica in food-producing animals, in particular in poultry. FUNDING Institut Pasteur, Institut de Veille Sanitaire, Fondation pour la Recherche Médicale, French Government Investissement d'Avenir programme.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(13)70124-5

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Human S. enterica serotype Kentucky isolates identified at the French National Reference Centre for Salmonella between 2000 and 2011
Figure 1 Human S. enterica serotype Kentucky isolates identified at the French National Reference Centre for Salmonella between 2000 and 2011CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 186

Metadata

Authors
Le Hello, S., Harrois, D., Bouchrif, B., Sontag, L., Elhani, D., Guibert, V., Zerouali, K., & Weill, F.-X.
Affiliations
  • Institut Pasteur (FR)
  • Institut Pasteur du Maroc (MA)
  • Centre Hospitalier Universitaire Ibn Rochd (MA)
Corresponding author
Weill, François-Xavier
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2013-08
Volume
13
Issue
8
Pages
672-679
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2074192765
Cited by
186
References
31
Citations by year
2026: 4 · 2025: 10 · 2024: 11 · 2023: 12 · 2022: 16 · 2021: 16 · 2020: 15 · 2019: 14 · 2018: 11 · 2017: 13 · 2016: 17 · 2015: 14 · 2014: 23 · 2013: 9
FWCI
31.32
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • Greater South Information System
Funders
French Government “Investissement d'Avenir” programme (ANR-10-LABX-62-IBEID)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
ciprofloxacin resistance, extended-spectrum cephalosporins, carbapenem resistance, antimicrobial resistance, extended-spectrum beta-lactamase, CTX-M-15, CMY-2, OXA-48, VIM-2, plasmid-mediated resistance genes, travel-associated transmission, molecular epidemiology, multilocus sequence typing
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Aminoglycosides, Anti-Bacterial Agents, Bacterial Proteins, beta-Lactamases, Child, Ciprofloxacin, Female, France, Humans, Male, Microbial Sensitivity Tests, Morocco, Salmonella Infections, Travel, Trimethoprim, Sulfamethoxazole Drug Combination, Azithromycin, Salmonella enterica, Drug Resistance, Multiple, Bacterial, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. https://app.cochat.ai/papers/10.1016/s1473-3099(13)70124-5
The paper
Le Hello, S., Harrois, D., Bouchrif, B., Sontag, L., Elhani, D., Guibert, V., Zerouali, K., & Weill, F.-X. (2013). Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(13)70124-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.